☰ Navigation Tabs
A consensus human beta defensin
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-1H COSY 1.3 mg/mL peptide 93% H2O/7% D2O 0 5.6 1 atm 298 Bruker AVANCE III 600 2 2D 1H-1H TOCSY 1.3 mg/mL peptide 93% H2O/7% D2O 0 5.6 1 atm 298 Bruker AVANCE III 600 3 2D 1H-1H NOESY 1.3 mg/mL peptide 93% H2O/7% D2O 0 5.6 1 atm 298 Bruker AVANCE 800 4 2D 1H-1H NOESY 1.3 mg/mL peptide 93% H2O/7% D2O 0 5.6 1 atm 298 Bruker AVANCE 800 5 2D 1H-15N HSQC 1.3 mg/mL peptide 93% H2O/7% D2O 0 5.6 1 atm 298 Bruker AVANCE III 600 6 2D 1H-13C HSQC 1.3 mg/mL peptide 93% H2O/7% D2O 0 5.6 1 atm 298 Bruker AVANCE III 600
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE III 600 2 Bruker AVANCE 800
NMR Refinement Method Details Software simulated annealing final refined by explicit water X-PLOR NIH
NMR Ensemble Information Conformer Selection Criteria structures with the lowest energy Conformers Calculated Total Number 100 Conformers Submitted Total Number 20 Representative Model 1 (closest to the average)
Computation: NMR Software # Classification Version Software Name Author 1 processing NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax 2 data analysis CARA Keller and Wuthrich 3 structure calculation X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore 4 refinement X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore